The ubiquitin-like modifier FAT10 does not affect IL-12 expression and signaling.

PLoS One

Division of Immunology, Department of Biology, University of Konstanz, Konstanz, Baden-Württemberg, Germany.

Published: May 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The ubiquitin-like modifier FAT10 is strongly expressed in dendritic cells (DCs) and upregulated during inflammation. Interleukin (IL)-12 plays a critical role in promoting CD4+ T cell differentiation into Th1 cells and in IFN-γ induction in T cells. Previously, it was shown that FAT10 is required for IFN-γ expression of activated T cells. In this study, we investigated whether FAT10 influences IL-12 expression or IL-12 induced signaling and thereby contributes to the reduced IFN-γ expression. Presence or absence of FAT10 did not alter IL-12 expression in DC2.4 cells and in bone marrow derived DCs. Furthermore, FAT10 had no influence on the differentiation of naïve T helper cells to Th1 cells under Th1 polarizing conditions. Additionally, FAT10 did not alter STAT4 phosphorylation in IL-12 receptor stimulated T cells. Taken together, FAT10 neither influences IL-12 expression in DCs nor affects IL-12 receptor signaling in T cells. Hence, the previously observed influence of FAT10 on IFN-γ secretion is not mediated by IL-12.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12054880PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0323005PLOS

Publication Analysis

Top Keywords

il-12 expression
16
fat10
9
il-12
9
cells
9
ubiquitin-like modifier
8
modifier fat10
8
th1 cells
8
cells fat10
8
ifn-γ expression
8
fat10 influences
8

Similar Publications

, a macrophage-residing parasite, expresses virulence factors that intercept macrophage signaling and inflicts leishmaniasis. Recently described virulence factors- eEF-1α (eukaryotic elongation factor), LmjF_36_3850 ( F_36_3850), LdTyrPIP_22 (LDBPK_220120.1) and LmjMAPK ( mitogen activated protein kinase)-4/12 selectively modulate the activities of kinases, phosphatases and metabolism of phosphatidylinositol influencing the infection outcome.

View Article and Find Full Text PDF

Background/aim: is a polyherbal formulation of 15 ingredients. It has antiinflammatory and antimicrobial properties and are effective in managing the symptoms of H1N1 swine flu and COVID-19. However, its mechanism of action is not fully understood.

View Article and Find Full Text PDF

Optimizing mucosal vaccination: Exploiting Lactobionic acid-modified chitosan for superior gene delivery systems.

Int J Biol Macromol

September 2025

CNC-UC - Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, 3004-504, Portugal; CIBB - Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, 3004-504, Portugal; Faculty of Pharmacy, University of Coimbra, Coimbra, 3000-548, Portugal. Electronic a

The increasing prevalence of respiratory disorders highlights the urgent need for effective mucosal vaccines that elicit targeted immune responses at pathogen entry sites. However, the advancement of mucosal vaccines is limited by challenges in antigen delivery and overcoming mucosal immune tolerance. In this study, we developed a gene delivery platform using chitosan functionalized with lactobionic acid (LA) to enhance targeting of antigen-presenting cells and to form stable DNA polyplexes with high transfection efficiency.

View Article and Find Full Text PDF

Neuroinflammation and neuronal death are direct consequences of persistent microglial activation observed in many chronic neurological conditions. Activated microglia impact neuronal cells by releasing proinflammatory cytokines and inflammatory mediators, leading to neuronal damage and neurodegeneration. To investigate whether Polyinosinic polycytidylic acid (poly I:C), a synthetic double-stranded RNA molecule, induces neuroinflammation and neuronal death, we exposed microglia (HMC-3 cells) to poly I: C for 24 hrs, and assessed inflammatory cytokines.

View Article and Find Full Text PDF

Tumors frequently evade immune destruction by impairing cytotoxic CD8 T-cell responses, highlighting the need for strategies that restore T-cell functionality. Here, we identify SLAMF7 (CD319) as a key enhancer of human CD8 T-cell responses against tumors. SLAMF7 expression is induced by pro-inflammatory signals such as IL-12 and CD28 co-stimulation.

View Article and Find Full Text PDF